Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
371.20    2.00 (0.54%)
Bid:
371.20
Ask:
371.40
Spread: 0.20 (0.054%)
Market Cap: £1.97b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Hammerson Issues £100m Bond Tap

31 Aug 2023 12:30

RNS Number : 9850K
Hammerson PLC
31 August 2023
 

Hammerson plc ("Hammerson" or the "Company")

31 August 2023

 

Hammerson issues £100m bond tap of existing £200m bonds maturing 2028

 

Hammerson announces that further to direct demand for Hammerson bonds, it has priced a £100m increase (or "tap") of its existing £200m 7.25% coupon bonds maturing in 2028, resulting in an outstanding notional of £300m1. The new bonds will have the same terms and conditions as the existing bonds. The new bonds will be placed with an existing large institutional investor.

Hammerson will use the proceeds for general corporate purposes including a tender offer for its £350m 3.5% bonds maturing in 2025 and £300m 6.0% bonds maturing in 2026 that has been announced earlier today.

The prospectus for the new bonds, when published, will be available on Hammerson's website (www.hammerson.com/investors/shareholder-information/debt-investors) and a copy will be submitted to the National Storage Mechanism and available to the public for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanismon.

Notes:

1. Subject to the signing of the subscription agreement

IMPORTANT DISCLAIMER: This announcement does not constitute an offer of any securities for sale (including, without limitation, the new bonds). The offer and sale of the new bonds may be restricted by law in certain jurisdictions. This announcement is not for release, publication or distribution in whole or in part, in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction.

The new bonds are not being, and will not be, offered or sold in the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia) (the "United States"). Nothing in this document constitutes an offer to sell or the solicitation of an offer to buy the new bonds in the United States or any other jurisdiction. Securities may not be offered, sold or delivered in the United States absent registration under, or an exemption from the registration requirements of, the Securities Act. The new bonds have not been, and will not be, registered under the Securities Act or the securities laws of any state or other jurisdiction of the United States and may not be offered, sold or delivered, directly or indirectly, within the United States or to, or for the account or benefit of, U.S. persons.

Compliance information for the new bonds: No EU PRIIPs KID - eligible counterparties and professional clients only (all distribution channels). No sales to EEA retail investors; no key information document in respect of the EEA has been or will be prepared. UK MiFIR professionals/ECPs only/No UK PRIIPs KID - eligible counterparties and professional clients only (all distribution channels). No sales to UK retail investors; no key information document in respect of the UK has been or will be prepared.

No action has been taken or will be taken in any jurisdiction in relation to the new bonds to permit a public offering of securities.

ENDS

 

Enquiries

Richard Sharp, Director of Treasury, Tax and Insurance

Tel: + 44 (0) 207 887 1119 E:richard.sharp@hammerson.com

 

Hammerson Investor Contacts

Josh Warren, Director of Strategy, Commercial Finance and Investor Relations

T: +44 (0) 20 7887 1053 E: josh.warren@hammerson.com

 

Hammerson Media Contacts

Natalie Gunson, Group Communications Director, Hammerson

T: +44 (0) 20 7887 4672 E: natalie.gunson@hammerson.com

 

MHP for Hammerson

Ollie Hoare and Charles Hirst

T: +44 (0)20 3128 8100 E: Hammerson@mhpgroup.com

 

Notes to editors

Hammerson has ratings of BBB (issuer default rating) from Fitch Ratings Limited ("Fitch") and Baa3 (long term debt) from Moody's Investors Services Limited ("Moody's"). The new bonds are expected to be assigned a BBB+ rating by Fitch and a Baa3 rating by Moody's. Morgan Stanley are acting as Sole Lead Manager on the issuance of the new bonds. Lloyds Bank Corporate Markets and Mizuho are acting as dealer managers on the tender offer referred to herein.

About Hammerson

Hammerson is a cities business. An owner, operator and developer of prime urban real estate, with a portfolio value of £4.7billion (as at 30 June 2023), in some of the fastest growing cities in the UK, Ireland and France.

Our portfolio and adjacent lands leverage our experience and capabilities to create and manage exceptional city centre destinations with the opportunity to drive value and reshape entire neighbourhoods.

Our assets are high profile and play an important role in our communities, welcoming more than 215 million visitors each year and supporting 20,000+ jobs though our retail, dining and social occupiers.

These destinations include Bullring in Birmingham, The Oracle in Reading, Dundrum Estate, Dublin and Terraces du Port in Marseille. We also hold investments in Value Retail, best-in-class villages such as Bicester Village, Oxfordshire.

Hammerson also holds 100 acres of attractive pre-development and strategic land. This includes complementary adjacent land, creating optionality to enhance both the scale and diversity of the existing estate, and stand-alone land opportunities. These include Martineau Galleries in Birmingham and Bishopsgate Goodsyard, Shoreditch.

 

www.hammerson.com

 

This announcement has also been released on the SENS system of the Johannesburg Stock Exchange and on Euronext Dublin.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IODFLFILTEILVIV
Date   Source Headline
30th Jun 202611:00 amRNSNotice of Half Year Results
30th Jun 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Jun 20267:00 amRNSNotification of Share Repurchase
8th Jun 202612:15 pmRNSAdmission to Trading
8th Jun 202611:00 amRNSDirector/PDMR Shareholding
5th Jun 20268:00 amRNSPublication of Final Terms
2nd Jun 20267:00 amRNSSuccessful pricing of 5-year EUR350m bond
29th May 20263:45 pmRNSHolding(s) in Company
26th May 202610:00 amRNSResults of Dividend Reinvestment Plan
22nd May 20264:15 pmRNSDirector/PDMR Shareholding
19th May 20262:00 pmRNSDirector/PDMR Shareholding
15th May 202612:30 pmRNSDirector/PDMR Shareholding
14th May 20263:00 pmRNSDirector/PDMR Shareholding
30th Apr 20264:30 pmRNSTotal Voting Rights
30th Apr 202611:15 amRNSResult of AGM
30th Apr 20267:00 amRNSHammerson CFO to retire
29th Apr 20267:00 amRNSHolding(s) in Company
28th Apr 20263:00 pmRNSDirector/PDMR Shareholding
24th Apr 20261:30 pmRNSEMTN Programme: Publication of Base Prospectus
24th Apr 20267:00 amRNSHolding(s) in Company
23rd Apr 20267:00 amRNSHolding(s) in Company
8th Apr 20264:00 pmRNSDirector/PDMR Shareholding
7th Apr 202612:45 pmRNSTotal Voting Rights and Capital
30th Mar 202610:00 amRNSDirector/PDMR Shareholding
26th Mar 202611:00 amRNSAnnual Report and Notice of Annual General Meeting
19th Mar 20262:00 pmRNSDirector/PDMR Shareholding
17th Mar 202610:00 amRNSDirector/PDMR Shareholding
17th Mar 20269:00 amRNSDividend Currency Conversion Announcement
25th Feb 20267:01 amRNSDividend Declaration
25th Feb 20267:00 amRNSFinal Results
6th Feb 20267:00 amRNSDirectorate change
28th Jan 20269:00 amRNSNotice of Results
20th Jan 20263:30 pmRNSHolding(s) in Company
22nd Dec 202511:30 amRNSDirector/PDMR Shareholding
22nd Dec 20259:30 amRNSDirector/PDMR Shareholding
15th Dec 20253:00 pmRNSDirector/PDMR Shareholding
11th Dec 20252:15 pmRNSTotal Voting Rights
11th Dec 20252:00 pmRNSDirector/PDMR Shareholding
3rd Dec 20257:00 amRNSDirectorate change
21st Nov 20257:00 amRNSAcquisition of The Oracle and Trading Update
13th Nov 20251:45 pmRNSDirector/PDMR Shareholding
31st Oct 20257:45 amRNSResults of Dividend Reinvestment Plan
28th Oct 20251:00 pmRNSDirector/PDMR Shareholding
24th Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 202511:00 amRNSDirector/PDMR Shareholding
22nd Oct 20254:30 pmRNSDirector/PDMR Shareholding
21st Oct 202512:00 pmRNSDirector/PDMR Shareholding
16th Oct 20251:00 pmRNSPublication of Final Terms
9th Oct 20257:00 amRNSBond Pricing, Guidance & Operational Update
25th Sep 20254:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.